Afrezza

MannKind, One Drop to study Afrezza-app combo in Type 2 diabetes

MannKind and One Drop are launching a study to gauge whether pairing the former's inhaled insulin with the latter's digital diabetes care platform will improve outcomes.

Amirah Al Idrus Aug 7, 2017 11:21am

Chutes & Ladders—Eli Lilly vet Derica Rice to retire as CFO

Jun 1, 2017 10:38pm